1. Home
  2. BDTX vs BYND Comparison

BDTX vs BYND Comparison

Compare BDTX & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • BYND
  • Stock Information
  • Founded
  • BDTX 2014
  • BYND 2009
  • Country
  • BDTX United States
  • BYND United States
  • Employees
  • BDTX N/A
  • BYND N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • BYND Packaged Foods
  • Sector
  • BDTX Health Care
  • BYND Consumer Staples
  • Exchange
  • BDTX Nasdaq
  • BYND Nasdaq
  • Market Cap
  • BDTX 181.4M
  • BYND 183.2M
  • IPO Year
  • BDTX 2020
  • BYND 2019
  • Fundamental
  • Price
  • BDTX $2.94
  • BYND $2.46
  • Analyst Decision
  • BDTX Strong Buy
  • BYND Sell
  • Analyst Count
  • BDTX 6
  • BYND 4
  • Target Price
  • BDTX $12.50
  • BYND $3.67
  • AVG Volume (30 Days)
  • BDTX 802.5K
  • BYND 2.2M
  • Earning Date
  • BDTX 11-04-2025
  • BYND 11-05-2025
  • Dividend Yield
  • BDTX N/A
  • BYND N/A
  • EPS Growth
  • BDTX N/A
  • BYND N/A
  • EPS
  • BDTX 0.25
  • BYND N/A
  • Revenue
  • BDTX $70,000,000.00
  • BYND $301,353,000.00
  • Revenue This Year
  • BDTX N/A
  • BYND N/A
  • Revenue Next Year
  • BDTX N/A
  • BYND $0.73
  • P/E Ratio
  • BDTX $11.74
  • BYND N/A
  • Revenue Growth
  • BDTX N/A
  • BYND N/A
  • 52 Week Low
  • BDTX $1.20
  • BYND $2.23
  • 52 Week High
  • BDTX $6.33
  • BYND $7.60
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 57.58
  • BYND 40.69
  • Support Level
  • BDTX $2.56
  • BYND $2.29
  • Resistance Level
  • BDTX $2.95
  • BYND $2.70
  • Average True Range (ATR)
  • BDTX 0.16
  • BYND 0.13
  • MACD
  • BDTX 0.02
  • BYND 0.02
  • Stochastic Oscillator
  • BDTX 79.00
  • BYND 41.46

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: